Pneumococcal conjugate vaccine

Invasive pneumococcal disease (IPD) is defined as the recovery of an isolate of S. pneumoniae from a normally sterile site, such as blood, cerebrospinal fluid (CSF), pleural fluid, joint aspirate, pericardial fluid, or peritoneal fluid [1]. Splenic abscesses are rare in the pediatric population [2]. Early recognition and intervention are critical due to the high mortality rate associated with delayed diagnosis [3]. A literature review revealed no case reports of splenic abscesses due to invasive pneumococcal

Pneumococcal and influenza vaccination are among one of the measures that can reduce the risk of otitis media (4). The major aim of introduction of vaccine in immunization program is to prevent diseases caused by Streptococcus pneumoniae. This is because the effectiveness in the use of antibiotic and other drugs was reduced due to drug resistance strains. There are two types of vaccine recommended for effective prevention of pneumococcal diseases. These vaccines are pneumococcal conjugate and pneumococcal

Another way to prevent pneumonia is to get vaccinated. There are two vaccines that are approved for adults one is called the pneumococcal conjugate vaccine and the other is called the pneumococcal polysaccharide vaccine. It is recommended for people over the age of 19 to receive the conjugate vaccine. The polysaccharide vaccine is recommended for adults 19 to 64 who qualify for the conjugate vaccine (Hess, pg.866). According to The American Lung Association, getting a flu shot every

Introduction In 2006, the United Nations Children’s Fund (UNICEF) and the World Health Organization (WHO) 1 published the report, Pneumonia: The forgotten killer of children which identified pneumonia as one of the world’s leading causes of childhood mortality accounting for one in five under-five deaths. The fourth Millennium Development Goal (MDG) from the 2000 summit is to reduce under-five mortality rate by two-thirds by 20151. With its significant contribution to under-five mortality, reduction

and new drug developments. Drug resistant Streptococcus pneumoniae, or more commonly known as DRSP is found in nearly every corner of the world but are more common in places that are less developed and therefore have a less access to a pneumococcal conjugate

Influenza Vaccine The immune system weakens with age, which makes seniors more susceptible to contracting seasonal influenza. Over ninety percent of deaths from the flu happen to those over 65 years of age. Seniors have the option of getting the regular flu vaccine or a higher-dose shot that results in a stronger immune response. Shingles Vaccine Shingles, otherwise known as herpes zoster, is a painful skin rash that occurs on one side of the face or body. The risk of getting shingles increases

Before vaccines existed, many people were caught ill with nasty, life-threatening diseases that can be lead to several complications and possibly death. (Department of Public Health, n.d.) You should always have the required immunisations and needles according to your status. By having the required immunisations according to your age and gender, you can save yourself from some very bad diseases and illnesses. Although our bodies generally try to fight these foreign organisms, some bacteria cannot

Following the introduction, over 97% of each vaccine eligible birth-cohort received ≥2 doses of the vaccine28. The aim of this study was to investigate the vaccine effectiveness of PHiD-CV10 against all-cause outpatient antimicrobial prescriptions for children <3 years of age in

Streptococcus pneumoniae was discovered by Louis Pasteur in pneumonia patients in 1881. It is a gram positive coccus that forms short chains or more commonly, pairs and classified in its own genus, called “Diplococcus”. Streptococcus pneumonie is a pneumococcal pneumonia consists about 85 % of all cases of pneumonia. Around ninety two different strains of S. Pneumoniae, collectively called pneumococci, are known to cause harm on humans. Streptococcus pneumonia is a member of pharyngeal microbiota that

vaccinations. “Prevnar 13 vaccine which is usually called (PCV13, PCV, Pneumococcal conjugate or Pneumococcal) is given to infants beginning at the age of two months up to fifteen months to prevent what is called invasive pneumococcal disease (IPD). This vaccination is given to protect against 13 common strains of pneumococcal bacteria, but it is not 100% effective.” However, PCV13 works with the natural defenses of the body to help develop immunity to disease. Therefore,